Getein Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Getein Biotech has a total shareholder equity of CN¥2.7B and total debt of CN¥763.6M, which brings its debt-to-equity ratio to 28.5%. Its total assets and total liabilities are CN¥3.8B and CN¥1.1B respectively. Getein Biotech's EBIT is CN¥173.1M making its interest coverage ratio -4.6. It has cash and short-term investments of CN¥944.7M.
Key information
28.5%
Debt to equity ratio
CN¥763.60m
Debt
Interest coverage ratio | -4.6x |
Cash | CN¥944.73m |
Equity | CN¥2.68b |
Total liabilities | CN¥1.09b |
Total assets | CN¥3.77b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603387's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.0B).
Long Term Liabilities: 603387's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥55.0M).
Debt to Equity History and Analysis
Debt Level: 603387 has more cash than its total debt.
Reducing Debt: 603387's debt to equity ratio has increased from 0% to 28.5% over the past 5 years.
Debt Coverage: 603387's debt is well covered by operating cash flow (55.2%).
Interest Coverage: 603387 earns more interest than it pays, so coverage of interest payments is not a concern.